Stock-Based Compensation | Stock-Based Compensation Total stock-based compensation expense by type of award was as follows for the years ended December 31: In Thousands 2019 2018 2017 Stock options $ 635 $ 1,209 $ 738 Stock appreciation rights (“SARs”) 2,906 894 1,543 Restricted Stock Awards 907 — — Stock grants 269 235 217 Total stock-based compensation expense $ 4,717 $ 2,338 $ 2,498 In 2010, the Board of Directors adopted a new stock option plan called the Encore Wire 2010 Stock Option Plan (As Amended and Restated Effective February 20, 2017) (the “2010 Stock Option Plan”) which was approved by the Company’s stockholders at the 2017 Annual Meeting of Stockholders. The 2010 Stock Option Plan permits the granting of securities in the form of unrestricted common stock, restricted common stock or options to purchase shares of common stock, to non-employee directors, officers and employees of the Company. The 2010 Stock Option Plan expired on February 20, 2020. We expect that a new equity incentive plan will be proposed in the Company's proxy statement to be voted on at the annual meeting of stockholders to be held on May 5, 2020. As of December 31, 2019, 399,800 securities remained available for grant in the form of unrestricted common stock, restricted common stock or options to purchase shares of common stock under the 2010 Stock Option Plan. Stock Options: No stock option awards were granted in 2019. The Company granted stock option awards in 2018 and 2017 with exercise prices equal to the fair market value of its stock on the date of grant of the options. These options vest ratably over a period of five years from the time the options were granted. The maximum term of any option granted under the 2010 Stock Option Plan is ten years. New shares are issued upon the exercise of options. The following presents a summary of stock option activity for the year ended December 31, 2019: Number Weighted Weighted Aggregate Outstanding at January 1, 2019 415,000 $ 41.53 Exercised (21,500) 26.39 Outstanding at December 31, 2019 393,500 $ 42.36 6.2 years $ 5,918 Vested and exercisable at December 31, 2019 209,700 $ 40.21 5.2 years $ 3,604 No stock option awards were granted in 2019. The fair value of stock options granted in the years ended December 31, 2018 and 2017, was estimated on the date of grant using a Black-Scholes option pricing model and the following weighted average assumptions: Year Ended December 31, 2018 2017 Risk-free interest rate 2.36 % 1.84 % Expected dividend yield 0.16 % 0.19 % Expected volatility 31.40 % 30.80 % Expected lives 5.0 years 5.0 years The Company bases expected volatilities on historical volatilities of Encore's common stock. The expected life represents the weighted average period of time that options granted are expected to be outstanding giving consideration to vesting periods and management’s consideration of historical exercise patterns. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding to the expected life of the option. The expected dividend yield is based on the annualized dividend payment paid on common shares. During the years ended December 31, 2018 and 2017, the weighted average grant date fair value of options granted was $15.95 and $12.46, respectively. During the years ended December 31, 2019, 2018 and 2017, the total intrinsic value of options exercised was $0.7 million, $0.9 million and $2.2 million, respectively. As of December 31, 2019, total unrecognized compensation cost related to non-vested stock options of $1.3 million was expected to be recognized over a weighted average period of 2.6 years. Stock Appreciation Rights: In 2014, the Board of Directors adopted a new stock appreciation rights plan called the Encore Wire 2014 Stock Appreciation Rights Plan (the “2014 SARs Plan”). The 2014 SARs Plan permits the grant of SARs that may only be settled in cash to non-executive officers and employees of the Company. SARs granted to employees vest ratably over a period of five ten The following presents a summary of SARs activity for the year ended December 31, 2019: Cash-settled SARs Weighted Weighted Aggregate Outstanding at January 1, 2019 471,100 $ 44.56 Granted 230,500 52.07 Exercised (119,900) 41.51 Forfeited/Canceled (16,400) 47.56 Outstanding at December 31, 2019 565,300 $ 48.18 8.0 years $ 5,217 Vested and exercisable at December 31, 2019 68,400 $ 44.34 6.4 years $ 893 The fair value of SARs granted during the years ended December 31, 2019, 2018 and 2017, was estimated on the date of grant using a Black-Scholes option pricing model and the following weighted average assumptions: Year Ended December 31, 2019 2018 2017 Risk-free interest rate 1.62 % 2.53 % 2.01 % Expected dividend yield 0.14 % 0.16 % 0.16 % Expected volatility 28.46 % 30.83 % 31.90 % Expected lives 3.0 years 3.0 years 3.2 years The Company bases expected volatilities on historical volatilities of Encore's common stock. The expected life represents the weighted average period of time that options granted are expected to be outstanding giving consideration to vesting periods and management’s consideration of historical exercise patterns. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding to the expected life of the option. The expected dividend yield is based on the annualized dividend payment paid on common shares. During the years ended December 31, 2019, 2018 and 2017, the weighted average grant date fair value of SARs granted was $17.19, $14.94 and $16.09, respectively, and the total intrinsic value of SARs exercised was $2.1 million, $1.1 million, and $0.3 million, respectively. As of December 31, 2019, total unrecognized compensation cost related to non-vested SARs of $5.9 million was expected to be recognized over a weighted average period of 3.2 years. Restricted Stock Awards: During the year ended December 31, 2019, the Company granted 60,000 shares of restricted stock to employees pursuant to the 2010 Stock Option Plan, with a weighted grant date fair value of $54.49 per share. There were no restricted shares issued in either 2018 or 2017. As of December 31, 2019, there was $2.3 million of total unrecognized compensation cost related to unvested shares. That cost is expected to be recognized over a weighted-average period of 4.4 years. The total fair value of shares vested during the year ending December 31, 2019 was $0.5 million. The following presents a summary of restricted stock activity for the year ended December 31, 2019: Weighted Average Number of Shares Grant Date Fair Value Outstanding at January 1, 2019 — — Granted 60,000 $ 54.49 Vested (10,000) 51.94 Forfeited/Canceled — — Unvested at December 31, 2019 50,000 $ 55.00 Stock Grants: In June 2019, the Company granted 1,000 shares of stock to each of the 5 non-employee directors pursuant to the 2010 Stock Option Plan with a grant date fair value of $53.81 per share. In May 2018, the Company granted 1,000 shares of stock to each of the 5 non-employee directors, with a grant date fair value of $46.95 per share. In May 2017, the Company granted 1,000 shares of stock to each of the 5 non-employee directors, with a grant date fair value of $43.40 per share |